Exhibit 99.2

Camtek Ltd.

and its Subsidiaries

Interim Condensed Consolidated

Financial Statements

As of September 30, 2021

(Unaudited)

Camtek Ltd. and its Subsidiaries

Interim Unaudited Condensed Consolidated Financial Statements as at September 30, 2021

Contents

Page

Interim Unaudited Condensed Consolidated Balance Sheets	F-3

Interim Unaudited Condensed Consolidated Statements of Operations	F-4 to F-5

Interim Unaudited Condensed Consolidated Statements of Shareholders’ Equity	F-6 to F-7

Interim Unaudited Condensed Consolidated Statements of Cash Flows	F-8 to F-9

Notes to the Interim Unaudited Condensed Consolidated Financial Statements	F-10 to F-16

Camtek Ltd. and its Subsidiaries

Interim Unaudited Condensed Consolidated Balance Sheets

		September 30,			December 31,
		2021			2020
	Note	U.S. Dollars (in thousands)
Assets

Current assets
Cash and cash equivalents	5A		117,852			105,815
Short-term deposits			87,000			72,000
Trade accounts receivable, net			61,178			41,001
Inventories	5B		56,968			39,736
Other current assets	5C		4,681			3,366

Total current assets			327,679			261,918

Long term deposits			10,000			-
Long term inventory	5B		4,832			4,416
Deferred tax assets			-			482
Other assets, net			119			85
Property, plant and equipment, net	5D		22,414			20,398
Intangible assets, net	5E		590			609

Total non-current assets			37,955			25,990

Total assets			365,634			287,908

Liabilities and shareholders’ equity

Current liabilities
Trade accounts payable			29,784			27,180
Other current liabilities	5F		52,888			30,204

Total current liabilities			82,672			57,384

Long term liabilities
Deferred tax liabilities, net			222			-
Other long-term liabilities			3,507			3,260
Total non-current liabilities			3,729			3,260

Total liabilities			86,401			60,644

Shareholders’ equity
Ordinary shares NIS 0.01 par value, 100,000,000 shares authorized at September 30, 2021 and at December 31, 2020;	3
45,934,072 issued shares at September 30, 2021 and 45,365,354 at December 31, 2020;
43,841,696 shares outstanding at September 30, 2021 and 43,272,978 at December 31, 2020;			172			171
Additional paid-in capital			174,948			170,497
Retained earnings			106,011			58,494
			281,131			229,162
Treasury stock, at cost (2,092,376 as of September 30, 2021 and December 31, 2020)			(1,898	)		(1,898	)

Total shareholders' equity			279,233			227,264

Total liabilities and shareholders' equity			365,634			287,908

The accompanying notes are an integral part of these interim unaudited condensed consolidated financial statements.

F - 3

Camtek Ltd. and its Subsidiaries

Interim Unaudited Condensed Consolidated Statements of Operations

(In thousands, except per share data)

		Nine months ended September 30,						Three months ended September 30,						Year ended December 31,
		2021			2020			2021			2020			2020
	Note	U.S. dollars						U.S. dollars						U.S. dollars
Revenues	4		195,488			107,240			70,686			40,061			155,859
Cost of revenues			95,724			57,315			34,893			20,636			82,628

Gross profit			99,764			49,925			35,793			19,425			73,231

Research and development costs			16,774			13,952			5,530			5,068			19,575
Selling, general and
administrative expenses	6A		31,406			21,374			10,118			8,036			31,032
			48,180			35,326			15,648			13,104			50,607

Operating income			51,584			14,599			20,145			6,321			22,624

Financial income, net	6B		911			958			349			307			775

Income from continuing
operations before taxes			52,495			15,557			20,494			6,628			23,399

Income tax expense			(4,978	)		(1,445	)		(1,989	)		(604	)		(1,621	)

Net income			47,517			14,112			18,505			6,024			21,778

F - 4

Camtek Ltd. and its Subsidiaries

Interim Unaudited Condensed Consolidated Statements of Operations (contd.)

Net income per ordinary share:

		Nine months ended				Three months ended				Year ended
		September 30,				September 30,				December 31,
		2021		2020		2021		2020		2020
	Note	U.S. dollars				U.S. dollars				U.S. dollars

Basic net earnings			1.09		0.36		0.42		0.15		0.55

Diluted net earnings			1.06		0.35		0.41		0.15		0.54

Weighted average number of
ordinary shares outstanding
(in thousands):

Basic			43,577		38,957		43,826		39,176		39,383

Diluted			44,627		39,878		44,658		40,066		40,372

The accompanying notes are an integral part of these interim unaudited condensed consolidated financial statements.

F - 5

Camtek Ltd. and its Subsidiaries

Interim Unaudited Condensed Consolidated Statements of Shareholders’ Equity

	Ordinary Shares				Number of						Additional				Total
	NIS 0.01 par value				Treasury			Treasury			paid-in		Retained		shareholders'
	Number of		U.S. Dollars		Shares			capital			earnings		capital		equity
	Shares Issued		(in thousands)		U.S. Dollars (in thousands)
Balances at
December 31, 2019		40,742,355		157		(2,092,376	)		(1,898	)		101,327		36,716		136,302

Share-based
compensation
expense		-		-		-			-			1,768		-		1,768
Exercise of share
options and RSUs		382,359		1		-			-			333		-		334
Net income		-		-		-			-			-		8,088		8,088

Balances at
June 30, 2020		41,124,714		158		(2,092,376	)		(1,898	)		103,428		44,804		146,492

Share-based
compensation
expense		-		-		-			-			1,297		-		1,297
Exercise of share
options and RSUs		179,043		1		-			-			184		-		185
Net income		-		-		-			-			-		6,024		6,024

Balances at
September 30, 2020		41,303,757		159		(2,092,376	)		(1,898	)		104,909		50,828		153,998

Balances at
December 31, 2020		45,365,354		171		(2,092,376	)		(1,898	)		170,497		58,494		227,264

Share-based
compensation
expense		-		-		-			-			2,681		-		2,681
Exercise of share
options and RSUs		439,508		1		-			-			205		-		206
Net income		-		-		-			-			-		29,012		29,012

Balances at
June 30, 2021		45,804,862		172		(2,092,376	)		(1,898	)		173,383		87,506		259,163

F - 6

Camtek Ltd. and its Subsidiaries

Interim Unaudited Condensed Consolidated Statements of Shareholders’ Equity (cont’d)

	Ordinary Shares				Number of						Additional				Total
	NIS 0.01 par value				Treasury			Treasury			paid-in		Retained		shareholders'
	Number of		U.S. Dollars		Shares			capital			earnings		capital		equity
	Shares Issued		(in thousands)		U.S. Dollars (in thousands)
Share-based
compensation
expense		-		-		-			-			1,512		-		1,512
Exercise of share
options and RSUs		129,210		*		-			-			53		-		53
Net income		-		-		-			-			-		18,505		18,505

Balances at
September 30, 2021		45,934,072		172		(2,092,376	)		(1,898	)		174,948		106,011		279,233

The accompanying notes are an integral part of these interim unaudited condensed consolidated financial statements.

F - 7

Camtek Ltd. and its Subsidiaries

Interim Unaudited Condensed Consolidated Statements of Cash Flows

(In thousands)

	Nine months ended September 30,						Three months ended September 30,						Year ended December 31,
	2021			2020			2021			2020			2020
	U.S. dollars						U.S. dollars						U.S. dollars
Cash flows from operating activities:
Net income		47,517			14,112			18,505			6,024			21,778
Adjustments to reconcile net income to net
cash provided by operating activities:
Depreciation and amortization		1,982			1,625			704			568			2,234
Deferred tax expense		704			738			36			512			476
Loss on disposal of fixed assets		31			-			-			-			-
Share based compensation expense		4,193			3,065			1,512			1,297			4,235
Change in provision for doubtful debts		(33	)		(83	)		-			(83	)		(87	)

Changes in operating assets and liabilities:
Trade accounts receivable, gross		(20,364	)		(2,360	)		(1,130	)		5,748			(9,696	)
Inventories		(19,045	)		(12,838	)		(3,863	)		(5,824	)		(19,330	)
Due from related parties, net		(13	)		56			(1	)		36			72
Other assets		(1,336	)		(146	)		(269	)		455			(501	)
Trade accounts payable		2,379			9,136			(3,661	)		(83	)		15,661
Other current liabilities		23,110			4,008			4,713			(3,757	)		10,686
Liability for employee severance benefits, net		7			110			(36	)		64			224

Net cash provided by operating activities		39,132			17,423			16,510			4,957			25,752

Cash flows from investing activities:
Release from (investment in) short-term deposits		(15,000	)		(28,500	)		22,000			(11,000	)		(20,500	)
Investment in long-term deposits		(10,000	)		-			-			-			-
Purchase of fixed assets		(2,514	)		(1,390	)		(1,246	)		(615	)		(2,410	)
Purchase of intangible assets		(60	)		(196	)		(15	)		(70	)		(216	)

Net cash provided by (used in) investing activities		(27,574	)		(30,086	)		20,739			(11,685	)		(23,126	)

Cash flows from financing activities:
Share issuance, net	-	-		-	-		64,288
Proceeds from exercise of share options	259	519		53	185		629

Net cash provided by financing activities	259	519		53	185		64,917
Effect of change in exchange rate on cash and cash equivalents	220	139		211	116		225

Net increase (decrease) in cash and cash
equivalents	12,037	(12,005	)	37,513	(6,427	)	67,768
Cash and cash equivalents at beginning of
the period	105,815	38,047		80,339	32,469		38,047

Cash and cash equivalents at end of the
period	117,852	26,042		117,852	26,042		105,815

F - 8

Camtek Ltd. and its Subsidiaries

Interim Unaudited Condensed Consolidated Statements of Cash Flows

(In thousands)

	Nine months ended September 30,				Three months ended September 30,				Year ended December 31,
	2021		2020		2021		2020		2020
	U.S. dollars				U.S. dollars				U.S. dollars
Supplementary cash flows information:
Income taxes paid		197		308		44		97		546
Interest received		785		825		386		382		1,420
Lease payments		699		780		218		250		1,025

Non-cash transactions:
Fixed assets purchased with supplier credit		81		152		81		152		159

The accompanying notes are an integral part of these interim unaudited condensed consolidated financial statements.

F - 9

Camtek Ltd. and its Subsidiaries

Notes to the Interim Unaudited Condensed Consolidated Financial Statements

(Amounts in thousands, except per share data)

Note 1 - Nature of Operations

Camtek Ltd. (“Camtek” or the “Company”), an Israeli corporation, is jointly controlled 20.9% by Priortech Ltd., an Israeli corporation listed on the Tel-Aviv Stock Exchange and 17.9% by Chroma Ate Inc., a Taiwanese company (“Chroma”). Camtek provides automated and technologically advanced solutions dedicated to enhancing production processes, increasing product yield and reliability, and enabling and supporting customers’ latest technologies in the semiconductor fabrication industry.

The Company’s shares are traded on the NASDAQ Global Market under the symbol “CAMT”, and also listed and traded on the Tel-Aviv stock exchange.

As detailed in the annual financial statements as of December 31, 2020, since January 2020, the Covid-19 outbreak has dramatically expanded into a worldwide pandemic creating macro-economic uncertainty and disruption in the business and financial markets. At present, business activity is continuing at all of the Company’s locations, with new routines implemented as required by local Covid-19 regulations.

From the beginning of the outbreak, the Company has been carefully managing the risks and its global operations. The Israeli facility has been able to maintain its required production levels. Worldwide, the Company has benefitted from its strategy of having in place local professional teams in each of its territories that can independently install and support systems. As such, the Company has been able to deliver most of its orders on time and the impact of the Covid-19 pandemic on the its business activity has not been significant.

F - 10

Camtek Ltd. and its Subsidiaries

Notes to the Interim Unaudited Condensed Consolidated Financial Statements

(Amounts in thousands, except per share data)

Note 2 - Basis of Preparation

A. Statement of compliance

Except as described below, the accounting policies applied in these interim financial statements are the same as those applied in the Company’s 2020 annual audited consolidated financial statement for the year ended December 31, 2020.

The accompanying unaudited condensed consolidated interim financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and do not include all of the information required for full annual financial statements. The unaudited condensed consolidated interim statements should be read in conjunction with the Company’s 2020 annual audited consolidated financial statements and footnotes, which were filed with the U.S. Securities and Exchange Commission as part of the Company’s Annual Report on Form 20-F for the year ended December 31, 2020.

In the opinion of management of the Company, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine-month periods ended September 30, 2021 are not necessarily indicative of the results that may be expected for the year ended December 31, 2021 or for any other future period.

B. Recent Accounting Pronouncements

In December 2019, the FASB issued Accounting Standard Update No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (ASU 2019-12), which simplifies the accounting for income taxes. This guidance became effective in the first quarter of 2021 on a prospective basis. The adoption of this guidance has not had a material impact on the Company’s consolidated financial statements.

F - 11

Camtek Ltd. and its Subsidiaries

Notes to the Interim Unaudited Condensed Consolidated Financial Statements

(Amounts in thousands, except per share data)

Note 3 - Shareholders’ Equity

A. Changes in Stock Options and RSUs

The number of stock options exercised in the three-month and nine-months period ended September 30, 2021, was 12,001 and 71,372, respectively. The number of restricted share units (RSUs) vested in the three-month and nine-month periods ended September 30, 2021, was 117,209 and 497,346, respectively.

B. Share-based Compensation Expense

In the first nine months of 2021, 191,842 RSUs and 5,704 stock options were granted by the Company. The RSUs and stock options vest over a four-year period.

The total share-based compensation expense amounted to $4,193, $3,065, $1,512, $1,297 and $4,235 for the nine-month periods ended September 30, 2021 and 2020, the three-month periods ended September 30, 2021 and 2020 and the year ended December 31, 2020, respectively.

Note 4 – Revenue Recognition

Revenues are attributable to geographic areas/countries based upon the destination of shipment of products and related services as follows:

	Nine months ended September 30,				Three months ended September 30,				Year ended December 31,
	2021		2020		2021		2020		2020
	U.S. Dollars (in thousands)

Asia Pacific		167,157		97,317		57,812		35,403		137,555
United States		15,268		4,425		6,441		1,167		9,847
Europe		13,063		5,498		6,433		3,491		8,457

		195,488		107,240		70,686		40,061		155,859

F - 12

Camtek Ltd. and its Subsidiaries

Notes to the Interim Unaudited Condensed Consolidated Financial Statements

(Amounts in thousands, except per share data)

Note 5 - Supplementary Financial Statements Information

A. Cash and cash equivalents

The Company’s cash and cash equivalent balance at September 30, 2021 and December 31, 2020 is denominated in the following currencies:

	September 30,		December 31,
	2021		2020
	U.S. Dollars

US Dollars		107,887		102,669
New Israeli Shekels		8,754		1,542
Euro		507		570
Other currencies		704		1,034

		117,852		105,815

B. Inventories

	September 30,		December 31,
	2021		2020
	U.S. Dollars

Components		31,256		19,630
Work in process		10,350		10,123
Finished products (including systems at customer locations not yet sold)		20,194		14,399

		61,800		44,152

Inventories are presented in:

	September 30,		December 31,
	2021		2020
	U.S. Dollars

Current assets		56,968		39,736
Non-current assets		4,832		4,416

		61,800		44,152

F - 13

Camtek Ltd. and its Subsidiaries

Notes to the Interim Unaudited Condensed Consolidated Financial Statements

(Amounts in thousands, except per share data)

Note 5 - Supplementary Financial Statements Information (cont’d)

C. Other Current Assets

	September 30,		December 31,
	2021		2020
	U.S. Dollars

Prepaid expenses		1,973		455
Due from Government institutions		1,739		1,967
Income tax receivables		324		302
Interest receivable		268		207
Deposits for operating leases		189		195
Other		188		240

		4,681		3,366

D. Property, Plant and Equipment, Net

	September 30,		December, 31
	2021		2020
	U.S. Dollars

Land		863		863
Building		14,698		14,438
Machinery and equipment		13,170		11,260
Office furniture and equipment		841		785
Computer equipment and software		5,130		4,760
Automobiles		479		263
Leasehold improvements		1,120		630
Right of use assets		3,376		3,014
		39,677		36,013

Less accumulated depreciation		17,263		15,615

		22,414		20,398

F - 14

Camtek Ltd. and its Subsidiaries

Notes to the Interim Unaudited Condensed Consolidated Financial Statements

(Amounts in thousands, except per share data)

Note 5 - Supplementary Financial Statements Information (cont’d)

E. Intangible Assets, Net

	September 30,		December 31,
	2021		2020
	U.S. Dollars

Patent registration costs		1,987		1,927

Accumulated amortization		1,397		1,318

Total intangible assets, net		590		609

F. Other Current Liabilities

	September 30,		December 31,
	2021		2020
	U.S. Dollars

Commissions		15,770		7,965
Advances from customers and deferred revenues		14,887		6,155
Accrued employee compensation and related benefits		10,643		9,698
Government institutions and income tax payable		4,910		752
Accrued warranty costs		3,549		2,328
Accrued expenses		2,493		2,570
Operating lease obligations		636		736

		52,888		30,204

F - 15

Camtek Ltd. and its Subsidiaries

Notes to the Interim Unaudited Condensed Consolidated Financial Statements

(Amounts in thousands, except per share data)

Note 6 - Statements of Operations

Selling, general and administrative expenses

	Nine months ended September 30,				Three months ended September 30,				Year ended December 31,
	2021		2020		2021		2020		2020
	U.S. Dollars (in thousands)

Selling (1)		24,451		15,397		7,816		5,846		22,969
General and administrative		6,955		5,977		2,302		2,190		8,063

		31,406		21,374		10,118		8,036		31,032
(1) Including shipping and handling costs		1,274		1,694		434		557		2,356

B. Financial income (expenses), net

	Nine months ended September 30,					Three months ended September 30,					Year ended December 31,
	2021		2020			2021		2020			2020
	U.S. Dollars (in thousands)

Interest income		900		1,047			339		318			1,281
Other, net (1)		11		(89	)		10		(11	)		(506	)

		911		958			349		307			775
(1) Including foreign currency expense resulting from transactions not denominated in U.S. Dollars		228		13			77		34			(351	)